ArticleClinicoEconomics and outcomes research : CEOR2026
Budget Impact of Secukinumab in Psoriatic Arthritis Patients with Contraindication to TNF-Alpha Inhibitors.
Unchalee Permsuwan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.